about
Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.miRGate: a curated database of human, mouse and rat miRNA-mRNA targetsCancer epigenetics: above and beyondEpigenetic research in cancer epidemiology: trends, opportunities, and challengesCell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma.MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1.
P2860
Q34119133-9F68F931-42FE-4B9F-9732-5EF2746B58D8Q35330866-866A3BD2-ADD5-4DEF-80C6-FF9543969972Q35844494-8A5AF88D-289B-4B13-956D-4955C79C0733Q37587537-B5B1FDA0-3DFF-4D84-A610-89DB6B6F7ACAQ41766645-7D4D6CB7-1E82-4F43-B34C-4E734A8EB6DFQ47162128-19E496F4-EA89-4BB6-B905-6E7E7B588C3EQ52629304-28858E34-CD07-45C7-B910-9AC6D9C21660
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenomics in cancer management.
@en
Epigenomics in cancer management.
@nl
type
label
Epigenomics in cancer management.
@en
Epigenomics in cancer management.
@nl
prefLabel
Epigenomics in cancer management.
@en
Epigenomics in cancer management.
@nl
P2860
P356
P1476
Epigenomics in cancer management.
@en
P2093
Fabricio F Costa
P2860
P304
P356
10.2147/CMR.S7280
P407
P577
2010-10-27T00:00:00Z